An unexpected name came up at a routine Boston Licensing Board hearing this morning: Dapper O'Neil. Read more.
Amrheins
Amrheins on West Broadway is blaming government handouts for how long it's taking its customers to get their food these days.
Amrheins is slated to be reborn as a much smaller cafe-style eatery when its block is turned into a life-sciences research building. In 2019, the developers planning that building paid Amrheins owner Stephen Mulrey $16.5 million for the current building and parking lot, according to Suffolk County Registry of Deeds records.
Update: Kara Baskin reports they will re-open for breakfast and lunch on Jan. 6.
Boston Restaurant Talk reports it's unclear whether this is for the winter or for good. In October, a developer filed plans to build an R&D building on the site, but keep Amrheins on the first floor, if in a smaller space.
The Matteson Companies and GFI Partners today filed plans with the BPDA to build an eight-story R&D building on what is now the Amrheins parking lot on West Broadway - and the single-story part of Amrheins, while saving the four-story apartment building housing the rest of Amrheins. Read more.
The Real Reporter reports (via Caught in Southie) that the Amrheins building on West Broadway is under agreement for sale to local developer Ryan Sillery. Read more.